Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,421 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Baloxavir Marboxil for Prophylaxis against Influenza in Household Contacts.
Ikematsu H, Hayden FG, Kawaguchi K, Kinoshita M, de Jong MD, Lee N, Takashima S, Noshi T, Tsuchiya K, Uehara T. Ikematsu H, et al. Among authors: kinoshita m. N Engl J Med. 2020 Jul 23;383(4):309-320. doi: 10.1056/NEJMoa1915341. Epub 2020 Jul 8. N Engl J Med. 2020. PMID: 32640124 Clinical Trial.
Ensitrelvir in patients with SARS-CoV-2: A retrospective chart review.
Yamato M, Kinoshita M, Miyazawa S, Seki M, Mizuno T, Sonoyama T. Yamato M, et al. Among authors: kinoshita m. J Infect Chemother. 2024 Sep;30(9):946-950. doi: 10.1016/j.jiac.2024.02.015. Epub 2024 Feb 15. J Infect Chemother. 2024. PMID: 38367932 Free article.
Comparative Effectiveness of Baloxavir Marboxil and Oseltamivir Treatment in Reducing Household Transmission of Influenza: A Post Hoc Analysis of the BLOCKSTONE Trial.
Ikematsu H, Baba T, Saito MM, Kinoshita M, Miyazawa S, Hata A, Nakano S, Kitanishi Y, Hayden FG. Ikematsu H, et al. Among authors: kinoshita m. Influenza Other Respir Viruses. 2024 May;18(5):e13302. doi: 10.1111/irv.13302. Influenza Other Respir Viruses. 2024. PMID: 38706384 Free PMC article. Clinical Trial.
Letter to the Editor regarding Response to "Letter to Editor: "Real-World Effectiveness of Ensitrelvir in Reducing Severe Outcomes in Outpatients at High Risk for COVID-19".
Takazono T, Fujita S, Komeda T, Miyazawa S, Yoshida Y, Kitanishi Y, Kinoshita M, Kojima S, Shen H, Uehara T, Hosogaya N, Iwanaga N, Mukae H. Takazono T, et al. Among authors: kinoshita m. Infect Dis Ther. 2024 Nov;13(11):2463-2467. doi: 10.1007/s40121-024-01054-6. Epub 2024 Sep 27. Infect Dis Ther. 2024. PMID: 39331323 Free PMC article. No abstract available.
3,421 results